The CFH gene may influence treatment outcomes in patients with AMD [139], proving to be much less effective in Y402H AMD patients treated with anti-VEGF and suggesting that the mutation may be a useful predictor of treatment response; additionally, rs1065489 and rs800292 influence treatment outcomes after anti-VEGF [140]. Here, CFH is linked to age-related macular degeneration.